| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥1.10 | -18.52% | ||
| CN¥1.10 | -18.52% | ||
| CN¥1.35 | -15.63% | ||
| CN¥1.35 | -15.63% | ||
| CN¥1.60 | 23.08% | ||
| CN¥1.30 | 4% | ||
| CN¥1.25 | 8.7% | ||
| CN¥1.15 | 25% | ||
| CN¥0.92 | 1.36% | ||
| CN¥0.9077 | 294.65% | ||
| CN¥0.23 | 0% | ||
| CN¥0.23 | 475% | ||
| CN¥0.04 | -36.51% | ||
Livzon Pharmaceutical Group Inc Class A pays a dividend yield (FWD) of 3.09%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €4.28
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Earnings Date
- Within the last 12 months, Livzon Pharmaceutical Group Inc Class A paid a dividend of CN¥2.45. For the next 12 months, Livzon Pharmaceutical Group Inc Class A is expected to pay a dividend of CN¥1.10. This corresponds to a dividend yield of approximately 3.09%.
- The dividend yield of Livzon Pharmaceutical Group Inc Class A is currently 3.09%.
- Livzon Pharmaceutical Group Inc Class A pays annually dividends. Payout is in July, June.
- The next dividend for Livzon Pharmaceutical Group Inc Class A is expected in July.
- Livzon Pharmaceutical Group Inc Class A paid dividend every year within the last 10 years.
- Dividends of CN¥1.10 are expected for the next 12 months. This corresponds to a dividend yield of 3.09%.
- Livzon Pharmaceutical Group Inc Class A is assigned to the sector "Health Care".
- The last stock split of Livzon Pharmaceutical Group Inc Class A was on 3 July 2019 in the ratio 13:10.
- To receive the last dividend of Livzon Pharmaceutical Group Inc Class A on 13 June 2025 in the amount of CN¥1.10 you had to have the stock in your portfolio before the ex-day on 13 June 2025.
- The last dividend was paid on 13 June 2025.
- In 2022, dividends of CN¥1.30 were paid by Livzon Pharmaceutical Group Inc Class A.
- Dividends from Livzon Pharmaceutical Group Inc Class A are paid in Chinese Yuan.
- The headquarters of Livzon Pharmaceutical Group Inc Class A is located in China.